Keywords: patients, benefit, after, switch, arimidex, anglo-swedish, drug

Patients benefit after switch to Arimidex

Article | 27 November 2006

Print This

Anglo-Swedish drug major AstraZeneca says that data published in the journal Lancet Oncology, has shown that women with early breast ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in